![]() |
Volumn 11, Issue 2, 2005, Pages 122-123
|
Cholesterol, racial variation and targeted medicines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN B;
CHOLESTEROL;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN RECEPTOR;
PROTEIN PCSK9;
SERINE PROTEINASE;
UNCLASSIFIED DRUG;
AFRICAN AMERICAN;
CHOLESTEROL BLOOD LEVEL;
DRUG RESPONSE;
FUNCTIONAL GENOMICS;
GENE OVEREXPRESSION;
GENETIC SCREENING;
GENETIC VARIABILITY;
HEART FAILURE;
HUMAN;
HYPERCHOLESTEROLEMIA;
NONSENSE MUTATION;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
RACE DIFFERENCE;
SHORT SURVEY;
AFRICAN AMERICANS;
ANIMALS;
CHOLESTEROL, LDL;
CODON, NONSENSE;
DRUG DESIGN;
HUMANS;
HYPERCHOLESTEROLEMIA;
MICE;
SERINE ENDOPEPTIDASES;
VASODILATOR AGENTS;
|
EID: 14644436462
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0205-122 Document Type: Short Survey |
Times cited : (8)
|
References (14)
|